Author:
Santoro A.,Gebbia V.,Pressiani T.,Testa A.,Personeni N.,Arrivas Bajardi E.,Foa P.,Buonadonna A.,Bencardino K.,Barone C.,Ferrari D.,Zaniboni A.,Tronconi M.C.,Cartenì G.,Milella M.,Comandone A.,Ferrari S.,Rimassa L.
Reference32 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer;Valle;N Engl J Med,2010
3. New and emerging treatment options for biliary tract cancer;Noel;Oncol Targets Ther,2013
4. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma—a retrospective study;Croitoru;J Gastrointestin Liver Dis,2012
5. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment;Capdevila;Cancer Treat Rev,2009
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献